BioCryst Pharmaceuticals, Inc. (BCRX)
9.67
+0.12
(+1.26%)
USD |
NASDAQ |
Aug 24, 16:00
9.77
+0.10
(+1.03%)
After-Hours: 20:00
BioCryst Pharmaceuticals Debt to Equity Ratio : -1.842 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.842 |
| March 31, 2026 | -1.549 |
| December 31, 2025 | -4.006 |
| September 30, 2025 | -1.761 |
| June 30, 2025 | -1.753 |
| March 31, 2025 | -1.835 |
| December 31, 2024 | -1.768 |
| September 30, 2024 | -1.797 |
| June 30, 2024 | -1.788 |
| March 31, 2024 | -1.791 |
| December 31, 2023 | -1.863 |
| September 30, 2023 | -2.057 |
| June 30, 2023 | -2.129 |
| March 31, 2023 | -2.301 |
| December 31, 2022 | -2.517 |
| September 30, 2022 | -2.975 |
| June 30, 2022 | -2.957 |
| March 31, 2022 | -3.733 |
| December 31, 2021 | -5.545 |
| September 30, 2021 | -2.113 |
| June 30, 2021 | -2.816 |
| March 31, 2021 | -3.857 |
| December 31, 2020 | -8.036 |
| September 30, 2020 | 2.401 |
| June 30, 2020 | 1.117 |
| Date | Value |
|---|---|
| March 31, 2020 | 23.37 |
| December 31, 2019 | 2.213 |
| September 30, 2019 | -2.049 |
| June 30, 2019 | -9.179 |
| March 31, 2019 | 3.735 |
| December 31, 2018 | 1.256 |
| September 30, 2018 | 0.8466 |
| June 30, 2018 | 1.119 |
| March 31, 2018 | 0.8575 |
| December 31, 2017 | 0.6533 |
| September 30, 2017 | 0.5418 |
| June 30, 2017 | 2.250 |
| March 31, 2017 | 1.400 |
| December 31, 2016 | 34.05 |
| September 30, 2016 | 13.39 |
| June 30, 2016 | 2.287 |
| March 31, 2016 | 1.094 |
| December 31, 2015 | 0.6784 |
| September 30, 2015 | 0.4684 |
| June 30, 2015 | 0.3943 |
| March 31, 2015 | 0.466 |
| December 31, 2014 | 0.3966 |
| September 30, 2014 | 0.3595 |
| June 30, 2014 | 0.333 |
| March 31, 2014 | -5.242 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Amgen, Inc. | 4.903 |
| Vertex Pharmaceuticals, Inc. | 0.0977 |
| Agenus, Inc. | -1.458 |
| Anika Therapeutics, Inc. | 0.1839 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 557.85M |
| Total Liabilities (Quarterly) | 1.012B |
| Shareholders Equity (Quarterly) | -454.29M |
| Current Ratio | 2.321 |
| Net Debt Paydown Yield | -0.06% |